CN108362809B - Quality evaluation method of ginkgo leaf and extract and preparation thereof - Google Patents
Quality evaluation method of ginkgo leaf and extract and preparation thereof Download PDFInfo
- Publication number
- CN108362809B CN108362809B CN201810103484.0A CN201810103484A CN108362809B CN 108362809 B CN108362809 B CN 108362809B CN 201810103484 A CN201810103484 A CN 201810103484A CN 108362809 B CN108362809 B CN 108362809B
- Authority
- CN
- China
- Prior art keywords
- glucoside
- kaempferol
- reference substance
- peak area
- rhamnoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000008100 Ginkgo biloba Nutrition 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 239000000284 extract Substances 0.000 title claims abstract description 18
- 238000013441 quality evaluation Methods 0.000 title claims abstract description 7
- 241000218628 Ginkgo Species 0.000 title claims description 9
- 235000011201 Ginkgo Nutrition 0.000 title claims description 9
- 239000013558 reference substance Substances 0.000 claims abstract description 46
- 229930003935 flavonoid Natural products 0.000 claims abstract description 38
- 150000002215 flavonoids Chemical class 0.000 claims abstract description 38
- 235000017173 flavonoids Nutrition 0.000 claims abstract description 38
- 238000012937 correction Methods 0.000 claims abstract description 24
- 238000011156 evaluation Methods 0.000 claims abstract description 12
- 239000000126 substance Substances 0.000 claims abstract description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 42
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 20
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000011550 stock solution Substances 0.000 claims description 11
- 239000012085 test solution Substances 0.000 claims description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 238000004364 calculation method Methods 0.000 claims description 9
- 239000009429 Ginkgo biloba extract Substances 0.000 claims description 8
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 claims description 7
- QJTYCCFDQWFJHU-UHFFFAOYSA-N Quercetin-5-O-beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC2=C1C(=O)C(O)=C(C=1C=C(O)C(O)=CC=1)O2 QJTYCCFDQWFJHU-UHFFFAOYSA-N 0.000 claims description 7
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 claims description 7
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 claims description 7
- SZDMSNWMQAMVTJ-UHFFFAOYSA-N quercetin-3-O-glucoside Natural products OC1OC(COC2=C(C(=O)c3cc(O)cc(O)c3O2)c4ccc(O)c(O)c4)C(O)C(O)C1O SZDMSNWMQAMVTJ-UHFFFAOYSA-N 0.000 claims description 7
- FZKBNCDAGYDHTP-UHFFFAOYSA-N quercetin-3-O-glycoside Natural products OC1C(O)C(O)C(O)OC1COC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O FZKBNCDAGYDHTP-UHFFFAOYSA-N 0.000 claims description 7
- 239000012488 sample solution Substances 0.000 claims description 7
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 4
- RTATXGUCZHCSNG-TYSPDFDMSA-N Kaempferol-3-O-rutinoside Natural products OC1[C@H](O)[C@@H](O)C(C)O[C@H]1OCC1[C@@H](O)[C@@H](O)C(O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 RTATXGUCZHCSNG-TYSPDFDMSA-N 0.000 claims description 4
- RTATXGUCZHCSNG-QHWHWDPRSA-N Nicotiflorin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 RTATXGUCZHCSNG-QHWHWDPRSA-N 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 4
- 239000012982 microporous membrane Substances 0.000 claims description 4
- RTATXGUCZHCSNG-ZFDPGQBLSA-N nicotiflorin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC2=C(c3ccc(O)cc3)Oc3c(c(O)cc(O)c3)C2=O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 RTATXGUCZHCSNG-ZFDPGQBLSA-N 0.000 claims description 4
- RTATXGUCZHCSNG-UHFFFAOYSA-N nicotiflorine Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 RTATXGUCZHCSNG-UHFFFAOYSA-N 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 claims 3
- HOUHSBKVSRPPGO-UHFFFAOYSA-N UNPD177615 Natural products OCC(O)C1OC(OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)cc4)C(O)C1O HOUHSBKVSRPPGO-UHFFFAOYSA-N 0.000 claims 3
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 claims 3
- ZZZILDYSXRHUNY-UHFFFAOYSA-N kaempferol-3-O-glucoside Natural products OC1OC(COC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)cc4)C(O)C(O)C1O ZZZILDYSXRHUNY-UHFFFAOYSA-N 0.000 claims 3
- 238000005303 weighing Methods 0.000 claims 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims 2
- 238000007865 diluting Methods 0.000 claims 2
- 229930003944 flavone Natural products 0.000 claims 2
- 150000002212 flavone derivatives Chemical class 0.000 claims 2
- 235000011949 flavones Nutrition 0.000 claims 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims 2
- SPUFXPFDJYNCFD-YQJBXTIASA-N 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 SPUFXPFDJYNCFD-YQJBXTIASA-N 0.000 claims 1
- NRSUOHVIKLCXEE-UHFFFAOYSA-N Isorhamnetin 3-O-beta-D-glucopyranoside Natural products CCC1OC(OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(OC)c4)C(O)C(O)C1O NRSUOHVIKLCXEE-UHFFFAOYSA-N 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- CQLRUIIRRZYHHS-LFXZADKFSA-N isorhamnetin 3-O-beta-D-glucopyranoside Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1 CQLRUIIRRZYHHS-LFXZADKFSA-N 0.000 claims 1
- SPUFXPFDJYNCFD-UHFFFAOYSA-N quercetin 3-O-rutinoside-7-O-glucoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(OC4C(C(O)C(O)C(CO)O4)O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 SPUFXPFDJYNCFD-UHFFFAOYSA-N 0.000 claims 1
- 238000009210 therapy by ultrasound Methods 0.000 claims 1
- 244000194101 Ginkgo biloba Species 0.000 abstract description 33
- 238000001514 detection method Methods 0.000 abstract description 10
- 239000007791 liquid phase Substances 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 238000005259 measurement Methods 0.000 abstract description 4
- 238000003908 quality control method Methods 0.000 abstract description 3
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 20
- 239000012071 phase Substances 0.000 description 20
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 18
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 16
- 239000007788 liquid Substances 0.000 description 14
- 230000014759 maintenance of location Effects 0.000 description 12
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 10
- 235000008777 kaempferol Nutrition 0.000 description 10
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 10
- 239000012088 reference solution Substances 0.000 description 9
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 8
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 235000005875 quercetin Nutrition 0.000 description 8
- 229960001285 quercetin Drugs 0.000 description 8
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 6
- 229940068052 ginkgo biloba extract Drugs 0.000 description 6
- 238000011002 quantification Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- LKZDFKLGDGSGEO-UJECXLDQSA-N kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O[C@H](CO)[C@@H](O)[C@@H]1O LKZDFKLGDGSGEO-UJECXLDQSA-N 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 238000012863 analytical testing Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000010812 external standard method Methods 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 238000000581 reactive spray deposition Methods 0.000 description 3
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 2
- 235000008800 isorhamnetin Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- -1 Ginkgo biflavonoids Chemical class 0.000 description 1
- 241000218791 Ginkgoaceae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical group CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/884—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种银杏叶及其提取物与制剂的质量评价方法,其属于中药材的质量检测技术领域。本发明通过构建银杏化学成分的高效液相指纹图谱,借助一测多评方法,计算校正因子,实现对银杏中多种黄酮类化学成分含量的测定。该方法操作简便,稳定性好,既可以客观、全面、准确地评价银杏叶及其提取物与制剂的品质,并用于其质量控制,又可解决因对照品缺乏而无法客观合理地控制药材及其提取物或制剂质量的问题,对控制质量和保证疗效具有重要意义。
A quality evaluation method for Ginkgo biloba leaves and its extracts and preparations belongs to the technical field of quality detection of Chinese medicinal materials. The invention realizes the determination of the content of various flavonoid chemical components in Ginkgo biloba by constructing the high-performance liquid phase fingerprint of the chemical components of Ginkgo biloba, and calculating the correction factor by means of a method of one measurement and multiple evaluations. The method is easy to operate and has good stability. It can not only objectively, comprehensively and accurately evaluate the quality of Ginkgo biloba leaves and their extracts and preparations, and use them for quality control, but also solve the problem of inability to objectively and rationally control medicinal materials due to lack of reference substances. The question of the quality of its extract or preparation is of great significance to control the quality and ensure the curative effect.
Description
技术领域technical field
本发明涉及中药材的质量检测技术领域,具体涉及一种基于高效液相指纹图谱和一测多评定量法的银杏叶及其提取物与制剂的质量评价方法。The invention relates to the technical field of quality detection of traditional Chinese medicinal materials, in particular to a quality evaluation method of Ginkgo biloba leaves and its extracts and preparations based on high-performance liquid phase fingerprint and one-measurement-multiple-evaluation method.
技术背景technical background
银杏叶为银杏科植物银杏Ginkgo biloba L.的干燥叶,具有活血化瘀,通络止痛、敛肺平喘,化浊降脂的功效。银杏化学成分丰富,包括黄酮类、内酯类和酚酸类等,其中银杏黄酮成分含量最多,组成多样,以总黄酮含量为24%的银杏提取物可改善心脑血管系统的各种疾病,且无副作用。Ginkgo biloba is the dry leaf of Ginkgo biloba L., a plant of the family Ginkgoaceae. Ginkgo biloba is rich in chemical components, including flavonoids, lactones and phenolic acids, among which Ginkgo biloba has the most flavonoids and various compositions. Ginkgo biloba extract with a total flavonoid content of 24% can improve various diseases of the cardiovascular and cerebrovascular system. And no side effects.
在银杏提取物与银杏制剂相关产品得到国内外医药领域的认可并获得大量市场需求的今天,银杏的质量评价方法至关重要。目前,在2015版《中国药典》银杏叶质量标准中:总黄酮含量是通过测定酸水解后槲皮素、山柰酚和异鼠李素的含量来评价和控制的,该方法不仅前处理繁琐,耗时长,而且不能充分反映黄酮类成分的真实和准确含量。此外,有研究报道了采用 HPLC-UV技术建立了银杏叶及其提取物中多种黄酮类化学成分的分析评价方法,但所测定指标对照品分离制备难度大、分析成本高,作为银杏药材质量控制方法不易推广。因此,为了充分控制好银杏叶药材及其提取物及其制剂的质量及临床安全性,开发一种简便易行、检测成本低廉,且可同时定量分析多种活性成分的分析方法,对于银杏及其提取物与制剂的质量控制具有现实意义。Today, when Ginkgo extract and Ginkgo preparation-related products have been recognized by domestic and foreign pharmaceutical fields and received a large number of market demands, the quality evaluation method of Ginkgo is very important. At present, in the 2015 edition of "Chinese Pharmacopoeia" Ginkgo biloba quality standard: the total flavonoid content is evaluated and controlled by measuring the content of quercetin, kaempferol and isorhamnetin after acid hydrolysis. , time-consuming, and cannot fully reflect the true and accurate content of flavonoids. In addition, some studies reported that an analytical evaluation method for various flavonoids in Ginkgo biloba leaves and its extracts was established by HPLC-UV technology, but the measured index reference substance was difficult to separate and prepare, and the analysis cost was high. The control method is not easy to generalize. Therefore, in order to fully control the quality and clinical safety of Ginkgo biloba medicinal materials and their extracts and their preparations, a simple and easy-to-implement, low-cost detection method that can quantitatively analyze multiple active components at the same time was developed. The quality control of its extracts and preparations has practical significance.
为此,本发明提供了一种基于高效液相指纹图谱和一测多评定量法的银杏叶及其提取物与制剂的质量评价方法。将银杏中一种黄酮成分作为内参物,通过相对校正因子的计算,实现对银杏中多种黄酮类化学成分含量的测定。该方法操作简便,稳定性好,既可以客观、全面、准确地评价银杏叶及其提取物与制剂的品质,又可解决因对照品缺乏而无法客观合理地评价品质的问题,对控制质量和保证疗效具有重要意义。To this end, the present invention provides a method for evaluating the quality of Ginkgo biloba leaves and its extracts and preparations based on high-performance liquid phase fingerprint and one-measurement-multiple-assessment method. A flavonoid component in Ginkgo biloba was used as an internal reference, and the content of various flavonoids in Ginkgo biloba was determined by calculating the relative correction factor. The method is easy to operate and has good stability, which can not only objectively, comprehensively and accurately evaluate the quality of Ginkgo biloba leaves and their extracts and preparations, but also solve the problem that the quality cannot be evaluated objectively and reasonably due to the lack of reference substances. Guaranteed efficacy is of great significance.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于针对现有技术的不足,提供一种测定银杏中多种黄酮成分的含量测定方法,该方法既能准确地评价银杏叶及其提取物与制剂中总黄酮的质量,也可以解决因对照品缺乏而无法客观合理地控制中药材及其制剂质量的问题。The object of the present invention is to aim at the deficiencies of the prior art, and to provide a method for measuring the content of various flavonoid components in Ginkgo biloba. Solve the problem that the quality of Chinese herbal medicines and their preparations cannot be controlled objectively and reasonably due to the lack of reference substances.
为了实现上述目的,本发明采用如下技术方案:In order to achieve the above object, the present invention adopts the following technical solutions:
提供一种银杏叶及其提取物与制剂的质量评价方法,该方法通过利用高效液相色谱技术以及一测多评方法,对银杏中多个黄酮类化学成分进行含量的测定,实现银杏叶及其提取物与制剂的客观、全面、准确地质量评价,黄酮类化学成分的含量测定是指银杏叶及其提取物与制剂的中多种黄酮对照品的含量测定,黄酮类化学成分的数量为8-16种。Provided is a method for evaluating the quality of Ginkgo biloba and its extracts and preparations. The method uses high performance liquid chromatography and a method of one measurement and multiple evaluations to measure the content of a plurality of flavonoid chemical components in Ginkgo biloba, so as to achieve Ginkgo biloba and Ginkgo biloba. The objective, comprehensive and accurate quality evaluation of its extracts and preparations, the content determination of flavonoid chemical components refers to the content determination of various flavonoid reference substances in Ginkgo biloba and its extracts and preparations, and the number of flavonoid chemical components is 8-16 species.
具体包括以下步骤:Specifically include the following steps:
1)对照品溶液的配制:分别精密称取各黄酮对照品1-5mg置于容量瓶中,用 80-100%甲醇溶解定容,然后过滤,制得各单一对照品储备液,然后分别量取不同体积单一标准品溶液,混合稀释制成含有多种黄酮成分的混合样品,作为混合对照品溶液,备用;1) Preparation of the reference substance solution: Precisely weigh 1-5 mg of each flavonoid reference substance and place it in a volumetric flask, dissolve it with 80-100% methanol to volume, and then filter to prepare each single reference substance stock solution, and then measure the Take a single standard solution of different volumes, mix and dilute to prepare a mixed sample containing a variety of flavonoids, which is used as a mixed reference solution for future use;
2)供试品溶液的配制:精密称取银杏叶、银杏提取物或者银杏制剂,加入浓度为50-100%甲醇,超声或加热提取、过滤,取续滤液过0.45um或0.22um滤膜,得样品溶液;2) Preparation of the test solution: Precisely weigh Ginkgo biloba leaves, Ginkgo biloba extract or Ginkgo biloba preparation, add methanol with a concentration of 50-100%, extract and filter by ultrasonic or heating, take the continuous filtrate and pass it through a 0.45um or 0.22um filter membrane, get the sample solution;
3)校正因子RCF的计算:取步骤1)中制得的混合对照品溶液2-20μL,用高效液相色谱测定色谱图并计算峰面积,选择其中一个化合物作为内参物,分别计算该内参物和其他化合物之间的相对校正因子fk/s。3) Calculation of correction factor RCF: Take 2-20 μL of the mixed reference solution prepared in step 1), measure the chromatogram with high performance liquid chromatography and calculate the peak area, select one of the compounds as the internal reference, and calculate the internal reference respectively. and the relative correction factor f k/s between other compounds.
其中,相对校正因子计算公式为:fk/s=fk/fs=AkCs/(AsCk)。式中:As为内参物峰面积;Cs为内参物浓度;Ak为某待测组分k 的峰面积;Ck为某待测组分k的浓度。The formula for calculating the relative correction factor is: f k/s =f k /f s =A k C s /(A s C k ). In the formula: A s is the peak area of the internal reference substance; C s is the concentration of the internal reference substance; Ak is the peak area of a certain component k to be measured; C k is the concentration of a certain component k to be measured.
4)样品中活性成分的测定:取步骤2)中制得的供试品溶液2-20μL,用用高效液相色谱测定色谱图,按以下公式分别计算出其他黄酮成分的质量;4) Determination of active ingredients in the sample: take 2-20 μL of the test solution prepared in step 2), measure the chromatogram with high performance liquid chromatography, and calculate the quality of other flavonoids according to the following formula;
所述公式为:Wk=(Ws╳Ak)/(fk/s╳As),Wk为被测组分的质量,Ws为内参物的质量,Ak为被测组分的峰面积,fk/s为校正因子,As为内参物的峰面积。The formula is: W k =(W s ╳A k )/(f k/s ╳A s ), W k is the mass of the tested component, W s is the mass of the internal reference, and A k is the tested component The peak area of the fraction, f k/s is the correction factor, and A s is the peak area of the internal reference.
本发明通过测定银杏叶及其提取物与制剂的中8-16种含量高、活性好的黄酮苷及其苷元成分多种黄酮对照品的总量,准确评价银杏总黄酮的含量。The invention accurately evaluates the total flavonoid content of Ginkgo biloba by measuring the total amount of 8-16 kinds of flavonoid glycosides with high content and good activity in Ginkgo biloba leaves and its extracts and preparations and various flavonoid reference substances of aglycone components.
黄酮对照品包括槲皮素-3-O-(2'',6"-二-O-α-L-鼠李糖基)-β-D-葡萄糖苷、山奈酚-3-0-(2'',6"-二-O-α-L-鼠李糖基)-β-D-葡萄糖苷、山奈酚-3-O-β槐糖苷、槲皮素-3-O-芸香糖-7-O-葡萄糖苷、3'-甲基-杨梅素-3-O-芸香糖苷、槲皮素 3-O-葡萄糖苷、槲皮素 3-O-(2-β-D-葡萄糖基-α-L-鼠李糖苷)、山奈酚-3-O-芸香糖苷、异鼠李素-3-O-β-D-芸香糖苷、山奈酚 3-(2''-β-D-葡萄糖苷)-α-L-鼠李糖苷、槲皮素 3-O-α-(6'''-p-香豆酰基-葡萄糖苷-β-1,4-鼠李糖苷)、山奈酚 3-O-α-(6'''-p-香豆酰基-葡萄糖苷-β-1,2-鼠李糖苷)。Flavonoid controls included quercetin-3-O-(2'',6"-di-O-α-L-rhamnosyl)-β-D-glucoside, kaempferol-3-0-(2 '',6"-di-O-α-L-rhamnosyl)-β-D-glucoside, kaempferol-3-O-β sophoroside, quercetin-3-O-rutose-7 -O-glucoside, 3'-methyl-myricetin-3-O-rutinoside, quercetin 3-O-glucoside, quercetin 3-O-(2-β-D-glucosyl-α -L-rhamnoside), kaempferol-3-O-rutinoside, isorhamnetin-3-O-β-D-rutinoside, kaempferol 3-(2''-β-D-glucoside) -α-L-rhamnoside, quercetin 3-O-α-(6'''-p-coumaroyl-glucoside-β-1,4-rhamnoside), kaempferol 3-O- α-(6'''-p-coumaroyl-glucoside-β-1,2-rhamnoside).
本发明通过高效液相色谱技术构建特征性液相指纹图谱,并保证黄酮类对照成分具有良好分离度(分离度≥1.2)。The present invention constructs a characteristic liquid phase fingerprint through high-performance liquid chromatography, and ensures that the flavonoid reference components have a good degree of separation (degree of separation ≥ 1.2).
高效液相色谱检测条件为:高效液相色谱仪的检测器使用二极管阵列检测器或通用型检测器,以八或十八烷基硅烷键合硅胶为填充剂,以乙腈为流动相A,以0.1%甲酸水溶液为流动相B,梯度洗脱,梯度洗脱过程中,流动相A、B的比例变化为:0-20min,A相15%-20%,B相85%-80%;20-25min,A相20%-30%,B相80%-70%;25-30min,A相30%-35%,B相70%-65%; 30-45min,A相35%-40%,B相65%-60%。采用紫外检测器是检测波长为210nm-360nm。流速为0.5ml/min-1.5ml/min,保持柱温20-45℃。The detection conditions of high performance liquid chromatography are as follows: the detector of the high performance liquid chromatograph uses a diode array detector or a general-purpose detector, with octadecylsilane bonded silica gel as the filler, acetonitrile as the mobile phase A, and 0.1% formic acid aqueous solution is mobile phase B, gradient elution, during gradient elution, the ratio of mobile phase A and B changes as follows: 0-20min, phase A 15%-20%, phase B 85%-80%; 20 -25min, A phase 20%-30%, B phase 80%-70%; 25-30min, A phase 30%-35%, B phase 70%-65%; 30-45min, A phase 35%-40% , B phase 65%-60%. The UV detector is used to detect wavelengths of 210nm-360nm. The flow rate was 0.5ml/min-1.5ml/min, and the column temperature was maintained at 20-45°C.
应用上述条件得到高效液相指纹图谱,各谱图相似度不低于0.90,各峰面积的RSD均不高于2%。Applying the above conditions to obtain high performance liquid phase fingerprints, the similarity of each spectrum is not less than 0.90, and the RSD of each peak area is not higher than 2%.
本发明中高效液相色谱柱型号优选为Gemini C18(250mm×4.6 mm,5.0μm),流速优选为0.8mL/min,检测波长优选为360nm,柱温优选为35ºC。In the present invention, the model of the high performance liquid chromatography column is preferably Gemini C18 (250 mm×4.6 mm, 5.0 μm), the flow rate is preferably 0.8 mL/min, the detection wavelength is preferably 360 nm, and the column temperature is preferably 35ºC.
本发明采用一测多评方法,以其中一种成分作为内参物,通过相对校正因子,分别计算各化合物的含量。其中,相对校正因子计算公式为:fk/s=fk/fs=AkCs/(AsCk)。式中:As为内参物峰面积;Cs为内参物浓度;Ak为某待测组分k 的峰面积;Ck为某待测组分k的浓度。The present invention adopts the method of one measurement and multiple evaluations, one of the components is used as an internal reference, and the content of each compound is calculated respectively through the relative correction factor. The formula for calculating the relative correction factor is: f k/s =f k /f s =A k C s /(A s C k ). In the formula: A s is the peak area of the internal reference substance; C s is the concentration of the internal reference substance; Ak is the peak area of a certain component k to be measured; C k is the concentration of a certain component k to be measured.
本发明具有以下优点:The present invention has the following advantages:
1)与传统方法相比,本发明解决了中药多成分定量和多指标质量控制中存在的操作繁琐、对照品缺乏等问题,在降低检测成分的同时,实现了多指标同步质量控制,准确反映中药产品质量。1) Compared with the traditional method, the present invention solves the problems of complicated operation and lack of reference substances in the multi-component quantification and multi-index quality control of traditional Chinese medicine. Quality of Chinese medicine products.
2)本发明将高效液相色谱技术与一测多评方法相结合,既符合指纹图谱相似度要求又符合含量要求的双重达标产品被确认为合格产品,对于控制不同批次产品间的质量一致性具有重要意义。2) The present invention combines high performance liquid chromatography technology with a multi-evaluation method, and the double-standard products that meet both the fingerprint similarity requirements and the content requirements are confirmed as qualified products, and the quality of products in different batches is controlled to be consistent. Sex is important.
3)本发明的方法以银杏中一种黄酮成分作为对照品,通过一测多评法同时定量银杏中槲皮素及其苷类、山奈酚及其苷类、异鼠李素及其苷类以及银杏双黄酮等多种黄酮成分含量,准确评价银杏叶及其提取物和制剂中总黄酮的含量。3) The method of the present invention uses a flavonoid component in Ginkgo biloba as a reference substance, and simultaneously quantifies quercetin and its glycosides, kaempferol and its glycosides, and isorhamnetin and its glycosides in Ginkgo biloba through a multi-evaluation method. As well as the content of various flavonoids such as Ginkgo biflavonoids, the content of total flavonoids in Ginkgo biloba leaves and their extracts and preparations can be accurately evaluated.
4)本发明所提供的一测多评法操作简便,且多指标质量评价方法稳定性好,可以客观、全面、准确地评价银杏叶及其提取物与制剂的品质,避免了传统方法中通过测定黄酮成分水解产物含量的评价方法,可有效杜绝了产品造假、修改工艺等问题。4) The one-test-multi-evaluation method provided by the present invention is easy to operate, and the multi-index quality evaluation method has good stability. The evaluation method for determining the content of hydrolyzate of flavonoids can effectively eliminate the problems of product counterfeiting and process modification.
附图说明Description of drawings
图1为银杏叶提取物的高效液相色谱图。Fig. 1 is the high performance liquid chromatogram of Ginkgo biloba extract.
图2为8种黄酮化合物组成的银杏叶混合标准品的高效液相色谱图。Fig. 2 is the high performance liquid chromatogram of the mixed standard product of Ginkgo biloba composed of 8 kinds of flavonoids.
图3为10种黄酮化合物组成的银杏叶混合标准品的高效液相色谱图。Figure 3 is a high performance liquid chromatogram of a mixed standard of Ginkgo biloba consisting of 10 flavonoids.
图4为12种黄酮化合物组成的银杏叶混合标准品的高效液相色谱图。Fig. 4 is the high performance liquid chromatogram of the mixed standard product of Ginkgo biloba composed of 12 kinds of flavonoids.
具体实施方式Detailed ways
下面结合具体实施例进一步阐明本发明,应理解这些实施例仅用于说明本发明而不用于先直奔发明的范围,本领域技术人员对于本发明的各种等价形式的修改菌落与本申请所有权要求所限定的范围。The present invention is further clarified below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not used to go straight to the scope of the invention. Those skilled in the art can modify colonies of various equivalent forms of the present invention and the present application. Scope limited by ownership requirements.
以下实施例中所用色谱条件:Chromatographic conditions used in the following examples:
1)仪器:高效液相色谱仪(华谱S6000,大连华谱科技发展有限公司);1) Instrument: high performance liquid chromatograph (Huapu S6000, Dalian Huapu Technology Development Co., Ltd.);
2)分析色谱柱:Gemini C18(250mm×4.6 mm,5.0μm,美国菲罗门公司);2) Analytical chromatographic column: Gemini C 18 (250mm×4.6mm, 5.0μm, Philomon Corporation, USA);
3)流动相:以乙腈为流动相A,以0.1%甲酸水溶液为流动相B,3) Mobile phase: use acetonitrile as mobile phase A, and use 0.1% formic acid aqueous solution as mobile phase B,
4)梯度条件: 流动相A、B的比例变化为:0—23min,16—17%A, 23—25min,17—20%A, 25—40min,20%A, 40—45min,20—28%A, 45—48m in, 28—35%A, 48—60min,35%A4) Gradient conditions: The ratio of mobile phase A and B changes as follows: 0—23min, 16—17%A, 23—25min, 17—20%A, 25—40min, 20%A, 40—45min, 20—28 %A, 45—48min, 28—35%A, 48—60min, 35%A
5)检测器条件:紫外检测器,检测波长为360nm5) Detector condition: UV detector, detection wavelength is 360nm
6)流速为0.8ml/min;6) The flow rate is 0.8ml/min;
7)柱温35℃。7) The column temperature is 35°C.
实施例1Example 1
下面结合图2及实施例进行详细说明:2 and the embodiment are described in detail below:
1)对照品1) Reference substance
槲皮素-3-O-(2'',6"-二-O-α-L-鼠李糖基)-β-D-葡萄糖苷(1)、山奈酚-3-0-(2'',6"-二-O-α-L-鼠李糖基)-β-D-葡萄糖苷(2)、槲皮素-3-O-芸香糖-7-O-葡萄糖苷(3)、槲皮素 3-O-葡萄糖苷(4)、异鼠李素-3-O-β-D-芸香糖苷(5)、山奈酚 3-(2''-β-D-葡萄糖苷)-α-L-鼠李糖苷(6)、槲皮素 3-O-α-(6'''-p-香豆酰基-葡萄糖苷-β-1,4-鼠李糖苷)(7)、山奈酚 3-O-α-(6'''-p-香豆酰基-葡萄糖苷-β-1,2-鼠李糖苷)(8)。Quercetin-3-O-(2'',6"-di-O-α-L-rhamnosyl)-β-D-glucoside (1), Kaempferol-3-0-(2' ',6"-di-O-α-L-rhamnosyl)-β-D-glucoside (2), quercetin-3-O-rutino-7-O-glucoside (3), Quercetin 3-O-glucoside (4), Isorhamnetin-3-O-β-D-rutinoside (5), Kaempferol 3-(2''-β-D-glucoside)-α -L-rhamnoside (6), quercetin 3-O-α-(6'''-p-coumaroyl-glucoside-β-1,4-rhamnoside) (7), kaempferol 3-O-α-(6'''-p-coumaroyl-glucoside-β-1,2-rhamnoside) (8).
2)样品溶液的制备2) Preparation of sample solution
精密称取银杏提取物粉末5.0mg于容量瓶中,加入甲醇溶解,超声5min,定容至20mL,摇匀,用0.22μm微孔滤膜过滤,为供试品溶液,采用高效液相色谱法进行分析检测。Precisely weigh 5.0 mg of Ginkgo biloba extract powder into a volumetric flask, add methanol to dissolve, ultrasonicate for 5 min, dilute to 20 mL, shake well, filter with 0.22 μm microporous membrane, and use high performance liquid chromatography as the test solution. Perform analytical testing.
3)对照品溶液的制备3) Preparation of reference solution
精密称取步骤1)中8种银杏黄酮单体化合物各1.0mg,分别容量瓶中,加甲醇溶解并定容至2ml,摇匀,制成各对照品的贮备溶液,浓度为0.5mg/mL。精密量取各对照品的贮备溶液2.0mL,置于同一25mL的容量瓶中,加甲醇溶解并稀释至刻度,摇匀,即得对照品混合溶液,过滤膜进入高效液相色谱仪。Precisely weigh 1.0 mg of each of the 8 Ginkgo flavonoid monomer compounds in step 1), add methanol to dissolve and dilute to 2 ml in a volumetric flask, shake well to prepare a stock solution of each reference substance with a concentration of 0.5 mg/mL . Precisely measure 2.0mL of the stock solution of each reference substance, put it in the same 25mL volumetric flask, add methanol to dissolve and dilute to the mark, shake well to obtain the reference substance mixed solution, and filter the membrane into the high performance liquid chromatograph.
4)校正因子的计算4) Calculation of correction factor
取步骤3)中制得的混合对照品溶液10μL,用高效液相色谱测定色谱图并计算峰面积,选择4号对照品作为内参物,分别计算该内参物和其他化合物之间的相对校正因子fk/s。相对校正因子计算公式为:fk/s=fk/fs=AkCs/(AsCk)。式中:As为内标物峰面积;Cs为内标物浓度;Ak为某待测组分k 的峰面积;Ck为某待测组分k 的浓度。Take 10 μL of the mixed reference substance solution prepared in step 3), measure the chromatogram with high performance liquid chromatography and calculate the peak area, select No. 4 reference substance as the internal reference substance, and calculate the relative correction factor between the internal reference substance and other compounds respectively f k/s . The calculation formula of the relative correction factor is: f k/s =f k /f s =A k C s /(A s C k ). In the formula: A s is the peak area of the internal standard; C s is the concentration of the internal standard; A k is the peak area of a certain component k to be measured; C k is the concentration of a certain component k to be measured.
4)其他黄酮成分的测定4) Determination of other flavonoids
取步骤2)中制得的供试品溶液10μL,用高效液相色谱测定色谱图,按以下公式分别计算出其他黄酮成分的质量;Take 10 μL of the test solution prepared in step 2), measure the chromatogram by high performance liquid chromatography, and calculate the mass of other flavonoids according to the following formula;
所述公式为:Wk=(Ws╳Ak)/(fk/s╳As),Wk为被测组分的质量,Ws为内参物的质量,Ak为被测组分的峰面积,fk/s为校正因子,As为内参物的峰面积。The formula is: W k =(W s ╳A k )/(f k/s ╳A s ), W k is the mass of the tested component, W s is the mass of the internal reference, and A k is the tested component The peak area of the fraction, f k/s is the correction factor, and A s is the peak area of the internal reference.
其梯度条件: 流动相A、B的比例变化为:0—23min,16—17%A, 23—25min,17—20%A, 25—40min,20%A, 40—45min,20—28%A, 45—48m in, 28—35%A, 48—60min,35%A;Its gradient conditions: The ratio of mobile phase A and B changes as follows: 0—23min, 16—17%A, 23—25min, 17—20%A, 25—40min, 20%A, 40—45min, 20—28% A, 45—48min, 28—35%A, 48—60min, 35%A;
实施例2Example 2
下面结合图3及实施例进行详细说明:3 and the embodiment are described in detail below:
1)对照品1) Reference substance
槲皮素-3-O-(2'',6"-二-O-α-L-鼠李糖基)-β-D-葡萄糖苷(1)、山奈酚-3-0-(2'',6"-二-O-α-L-鼠李糖基)-β-D-葡萄糖苷(2)、槲皮素-3-O-芸香糖-7-O-葡萄糖苷(3)、3'-甲基-杨梅素-3-O-芸香糖苷(4)、槲皮素 3-O-葡萄糖苷(5)、山奈酚-3-O-芸香糖苷(6)、异鼠李素-3-O-β-D-芸香糖苷(7)、山奈酚 3-(2''-β-D-葡萄糖苷)-α-L-鼠李糖苷(8)、槲皮素 3-O-α-(6'''-p-香豆酰基-葡萄糖苷-β-1,4-鼠李糖苷)(9)、山奈酚 3-O-α-(6'''-p-香豆酰基-葡萄糖苷-β-1,2-鼠李糖苷)(10)。Quercetin-3-O-(2'',6"-di-O-α-L-rhamnosyl)-β-D-glucoside (1), Kaempferol-3-0-(2' ',6"-di-O-α-L-rhamnosyl)-β-D-glucoside (2), quercetin-3-O-rutino-7-O-glucoside (3), 3'-Methyl-myricetin-3-O-rutinoside (4), Quercetin 3-O-glucoside (5), Kaempferol-3-O-rutinoside (6), Isorhamnetin- 3-O-β-D-rutinoside (7), kaempferol 3-(2''-β-D-glucoside)-α-L-rhamnoside (8), quercetin 3-O-α -(6'''-p-coumaroyl-glucoside-β-1,4-rhamnoside) (9), kaempferol 3-O-α-(6'''-p-coumaroyl- glucoside-beta-1,2-rhamnoside) (10).
2)样品溶液的制备2) Preparation of sample solution
精密称取银杏提取物粉末5.0mg于容量瓶中,加入甲醇溶解,超声5min,定容至20mL,摇匀,用0.22μm微孔滤膜过滤,为供试品溶液,采用高效液相色谱法进行分析检测。Precisely weigh 5.0 mg of Ginkgo biloba extract powder into a volumetric flask, add methanol to dissolve, ultrasonicate for 5 min, dilute to 20 mL, shake well, filter with 0.22 μm microporous membrane, and use high performance liquid chromatography as the test solution. Perform analytical testing.
3)对照品溶液的制备3) Preparation of reference solution
精密称取步骤1)中10种银杏黄酮单体化合物各1.0mg,分别容量瓶中,加甲醇溶解并定容至2.0ml,摇匀,制成各对照品的贮备溶液,浓度为0.5mg/mL。精密量取各对照品的贮备溶液2.0mL,置于同一25mL的容量瓶中,加甲醇溶解并稀释至刻度,摇匀,即得对照品混合溶液,过滤膜进入高效液相色谱仪。Precisely weigh 1.0 mg of each of the 10 Ginkgo flavonoid monomer compounds in step 1) into a volumetric flask, add methanol to dissolve and dilute to 2.0 ml, shake well, and prepare a stock solution of each reference substance with a concentration of 0.5 mg/ mL. Precisely measure 2.0mL of the stock solution of each reference substance, put it in the same 25mL volumetric flask, add methanol to dissolve and dilute to the mark, shake well to obtain the reference substance mixed solution, and filter the membrane into the high performance liquid chromatograph.
4)校正因子的计算4) Calculation of correction factor
取步骤3)中制得的混合对照品溶液10μL,用高效液相色谱测定色谱图并计算峰面积,选择5号对照品作为内参物,分别计算该内参物和其他化合物之间的相对校正因子fk/s。相对校正因子计算公式为:fk/s=fk/fs=AkCs/(AsCk)。式中:As为内标物峰面积;Cs为内标物浓度;Ak为某待测组分k 的峰面积;Ck为某待测组分k 的浓度。Take 10 μL of the mixed reference solution prepared in step 3), measure the chromatogram with high performance liquid chromatography and calculate the peak area, select No. 5 reference substance as the internal reference, and calculate the relative correction factor between the internal reference and other compounds respectively f k/s . The calculation formula of the relative correction factor is: f k/s =f k /f s =A k C s /(A s C k ). In the formula: A s is the peak area of the internal standard; C s is the concentration of the internal standard; A k is the peak area of a certain component k to be measured; C k is the concentration of a certain component k to be measured.
4)其他黄酮成分的测定4) Determination of other flavonoids
取步骤2)中制得的供试品溶液10μL,用高效液相色谱测定色谱图,按以下公式分别计算出其他黄酮成分的质量;Take 10 μL of the test solution prepared in step 2), measure the chromatogram by high performance liquid chromatography, and calculate the mass of other flavonoids according to the following formula;
所述公式为:Wk=(Ws╳Ak)/(fk/s╳As),Wk为被测组分的质量,Ws为内参物的质量,Ak为被测组分的峰面积,fk/s为校正因子,As为内参物的峰面积。The formula is: W k =(W s ╳A k )/(f k/s ╳A s ), W k is the mass of the tested component, W s is the mass of the internal reference, and A k is the tested component The peak area of the fraction, f k/s is the correction factor, and A s is the peak area of the internal reference.
其梯度条件: 流动相A、B的比例变化为:0—23min,16—17%A, 23—25min,17—20%A, 25—40min,20%A, 40—45min,20—28%A, 45—48m in, 28—35%A, 48—60min,35%A;Its gradient conditions: The ratio of mobile phase A and B changes as follows: 0—23min, 16—17%A, 23—25min, 17—20%A, 25—40min, 20%A, 40—45min, 20—28% A, 45—48min, 28—35%A, 48—60min, 35%A;
实施例3Example 3
下面结合图4及实施例进行详细说明:4 and the embodiment are described in detail below:
1)对照品1) Reference substance
槲皮素-3-O-(2'',6"-二-O-α-L-鼠李糖基)-β-D-葡萄糖苷(1)、山奈酚-3-0-(2'',6"-二-O-α-L-鼠李糖基)-β-D-葡萄糖苷(2)、山奈酚-3-O-β槐糖苷(3)、槲皮素-3-O-芸香糖-7-O-葡萄糖苷(4)、3'-甲基-杨梅素-3-O-芸香糖苷(5)、槲皮素 3-O-葡萄糖苷(6)、槲皮素 3-O-(2-β-D-葡萄糖基-α-L-鼠李糖苷)(7)、山奈酚-3-O-芸香糖苷(8)、异鼠李素-3-O-β-D-芸香糖苷(9)、山奈酚 3-(2''-β-D-葡萄糖苷)-α-L-鼠李糖苷(10)、槲皮素 3-O-α-(6'''-p-香豆酰基-葡萄糖苷-β-1,4-鼠李糖苷)(11)、山奈酚 3-O-α-(6'''-p-香豆酰基-葡萄糖苷-β-1,2-鼠李糖苷)(12)。Quercetin-3-O-(2'',6"-di-O-α-L-rhamnosyl)-β-D-glucoside (1), Kaempferol-3-0-(2' ',6"-di-O-α-L-rhamnosyl)-β-D-glucoside (2), kaempferol-3-O-β sophoroside (3), quercetin-3-O - Rutino-7-O-glucoside (4), 3'-methyl-myricetin-3-O-rutinoside (5), Quercetin 3-O-glucoside (6), Quercetin 3 -O-(2-β-D-glucosyl-α-L-rhamnoside) (7), kaempferol-3-O-rutinoside (8), isorhamnetin-3-O-β-D - Rutinoside (9), Kaempferol 3-(2''-β-D-glucoside)-α-L-rhamnoside (10), Quercetin 3-O-α-(6'''- p-coumaroyl-glucoside-β-1,4-rhamnoside) (11), kaempferol 3-O-α-(6'''-p-coumaroyl-glucoside-β-1, 2-rhamnoside) (12).
2)样品溶液的制备2) Preparation of sample solution
精密称取银杏提取物粉末5.0mg于容量瓶中,加入甲醇溶解,超声5min,定容至20mL,摇匀,用0.22μm微孔滤膜过滤,为供试品溶液,采用高效液相色谱法进行分析检测。Precisely weigh 5.0 mg of Ginkgo biloba extract powder into a volumetric flask, add methanol to dissolve, ultrasonicate for 5 min, dilute to 20 mL, shake well, filter with 0.22 μm microporous membrane, and use high performance liquid chromatography as the test solution. Perform analytical testing.
3)对照品溶液的制备3) Preparation of reference solution
精密称取步骤1)中12种银杏黄酮单体化合物各1.0mg,分别容量瓶中,加甲醇溶解并定容至2ml,摇匀,制成各对照品的贮备溶液,浓度为0.5mg/mL。精密量取各对照品的贮备溶液1.5mL,置于同一25mL的容量瓶中,加甲醇溶解并稀释至刻度,摇匀,即得对照品混合溶液,过滤膜进入高效液相色谱仪。Precisely weigh 1.0 mg of each of the 12 Ginkgo flavonoid monomer compounds in step 1) into a volumetric flask, add methanol to dissolve and dilute to 2 ml, shake well, and prepare a stock solution of each reference substance with a concentration of 0.5 mg/mL . Precisely measure 1.5mL of the stock solution of each reference substance, put it in the same 25mL volumetric flask, add methanol to dissolve and dilute to the mark, shake well to obtain the reference substance mixed solution, and filter the membrane into the high performance liquid chromatograph.
4)校正因子的计算4) Calculation of correction factor
取步骤3)中制得的混合对照品溶液10μL,用高效液相色谱测定色谱图并计算峰面积,选择6号对照品作为内参物,分别计算该内参物和其他化合物之间的相对校正因子fk/s。相对校正因子计算公式为:fk/s=fk/fs=AkCs/(AsCk)。式中:As为内标物峰面积;Cs为内标物浓度;Ak为某待测组分k 的峰面积;Ck为某待测组分k 的浓度。Take 10 μL of the mixed reference solution prepared in step 3), measure the chromatogram with high performance liquid chromatography and calculate the peak area, select No. 6 reference substance as the internal reference, and calculate the relative correction factor between the internal reference and other compounds respectively f k/s . The calculation formula of the relative correction factor is: f k/s =f k /f s =A k C s /(A s C k ). In the formula: A s is the peak area of the internal standard; C s is the concentration of the internal standard; A k is the peak area of a certain component k to be measured; C k is the concentration of a certain component k to be measured.
4)其他黄酮成分的测定4) Determination of other flavonoids
取步骤2)中制得的供试品溶液10μL,用高效液相色谱测定色谱图,按以下公式分别计算出其他黄酮成分的质量;Take 10 μL of the test solution prepared in step 2), measure the chromatogram by high performance liquid chromatography, and calculate the mass of other flavonoids according to the following formula;
所述公式为:Wk=(Ws╳Ak)/(fk/s╳As),Wk为被测组分的质量,Ws为内参物的质量,Ak为被测组分的峰面积,fk/s为校正因子,As为内参物的峰面积。The formula is: W k =(W s ╳A k )/(f k/s ╳A s ), W k is the mass of the tested component, W s is the mass of the internal reference, and A k is the tested component The peak area of the fraction, f k/s is the correction factor, and A s is the peak area of the internal reference.
其梯度条件: 流动相A、B的比例变化为:0—23min,16—17%A, 23—25min,17—20%A, 25—40min,20%A, 40—45min,20—28%A, 45—48m in, 28—35%A, 48—60min,35%A;Its gradient conditions: The ratio of mobile phase A and B changes as follows: 0—23min, 16—17%A, 23—25min, 17—20%A, 25—40min, 20%A, 40—45min, 20—28% A, 45—48min, 28—35%A, 48—60min, 35%A;
实施例4Example 4
下面结合和图3对本发明进一步说明The present invention will be further described below in conjunction with FIG. 3
方法学的考察的实施案例Implementation cases of methodological inspections
1)线性关系、最低检测限(LOD)和最低定量限(LOQ)试验1) Linearity, lower limit of detection (LOD) and lower limit of quantification (LOQ) assays
精密吸取对照品为10种化合物的标准溶液溶液8、20、40、80、160、320、640ug/ml,进样量10 uL,注入液相色谱仪,记录峰面积,以各对照品浓度为横坐标,峰面积为纵坐标,绘制标准曲线,以S/N =3 确定方法的检出限,以S/N =10确定方法的定量限,检出限、定量限及线性回归方程等参数,结果显示好的线性关系(r2大于等于0.9993),检测限0.13-1.11,定量限0.43-3.69,相对校正因子的RSD在0.23-1.34,相对保留时间在0.05-0.72。Accurately draw the standard solutions of 10 compounds, 8, 20, 40, 80, 160, 320, 640ug/ml, and inject 10 uL into the liquid chromatograph, record the peak area, and take the concentration of each reference substance as The abscissa, the peak area as the ordinate, draw a standard curve, and determine the detection limit of the method with S/N =3, and determine the quantification limit of the method with S/N =10, the detection limit, the quantification limit and the linear regression equation and other parameters , the results showed a good linear relationship (r 2 greater than or equal to 0.9993), the detection limit was 0.13-1.11, the quantification limit was 0.43-3.69, the RSD of the relative correction factor was 0.23-1.34, and the relative retention time was 0.05-0.72.
回归方程、线性范围及最低检测限和最低定量限Regression equation, linear range, and LOD and LQ
2)精密度、重复性、稳定性和准确度试验:2) Precision, repeatability, stability and accuracy test:
精密度:取对照品溶液,在确定的色谱条件下分别在一日内重复进样6次和在连续3 日内重复进样6次,以所分析的各成分峰面积的相对标准偏差(RSD)和保留时间(RT)来评价日内及日间精密度,精密度结果显示日内A(峰面积)和RT(保留时间)的RSD分别低于0.89、0.75,日间A(峰面积)和RT(保留时间)的RSD分别低于1.86、0.6,表示精密度良好。Precision: Take the reference solution, repeat the injection 6 times within one day and 6 times within 3 consecutive days under the determined chromatographic conditions, and calculate the relative standard deviation (RSD) and the peak area of each component analyzed. Retention time (RT) was used to evaluate intra-day and inter-day precision. The precision results showed that the RSDs of intra-day A (peak area) and RT (retention time) were lower than 0.89 and 0.75, respectively, and inter-day A (peak area) and RT (retention time) time), the RSDs were lower than 1.86 and 0.6, respectively, indicating good precision.
稳定性试验:取同一份混合标准品溶液,分别于0,2,4,6,8,12,24,48时注入液相色谱仪,以各成份分峰面积RSD和保留时间(RT)考察其稳定性,稳定性A(峰面积)和RT(保留时间)的RSD分别为0.66-1.92、0.13-1.18,表示样品溶液在48h内稳定。Stability test: Take the same mixed standard solution and inject it into the liquid chromatograph at 0, 2, 4, 6, 8, 12, 24, and 48, respectively, and investigate the peak area RSD and retention time (RT) of each component. Its stability, the RSD of stability A (peak area) and RT (retention time) were 0.66-1.92 and 0.13-1.18, respectively, indicating that the sample solution was stable within 48h.
重复性试验:取混合标准品溶液(平行6份),在上述色谱条件下进样分析,以样品中各成分含量的RSD保留时间(RT)值来评价其稳定性,重复性A(峰面积)和RT(保留时间)的RSD分别为0.67-1.96,0.05-0.51,表示样品溶液重复性良好。Repeatability test: take the mixed standard solution (6 copies in parallel), inject and analyze under the above chromatographic conditions, and evaluate its stability with the RSD retention time (RT) value of each component content in the sample. Repeatability A (peak area) ) and RT (retention time) RSDs were 0.67-1.96 and 0.05-0.51, respectively, indicating that the sample solution had good repeatability.
精密度、重复性和稳定性试验Precision, Repeatability and Stability Testing
准确度实验:通过加样回收率实验评价方法的准确度,精密称取适量已知含量的银杏药材粉末1g,加入一定量的对照品溶液,按供试品溶液制备样品,制成低、中、高三个浓度(50%、80%、100%)测定,计算加样回收率,回收率=(测量值-原始值)/加入的标准值,回收率在98.8-102.1,RSD在0.32-1.76,结果表明,本方法具有良好的准确度。Accuracy experiment: To evaluate the accuracy of the method through the sample addition recovery experiment, accurately weigh 1 g of Ginkgo biloba powder with known content, add a certain amount of reference solution, prepare samples according to the test solution, and make low and medium , three high concentrations (50%, 80%, 100%) were measured, and the recovery rate of sample addition was calculated. Recovery rate = (measured value - original value) / added standard value, the recovery rate was 98.8-102.1, and the RSD was 0.32-1.76 , the results show that this method has good accuracy.
方法的适用性考察:Applicability of the method to check:
为了检测新方法,实验考察了实验室现有不同的液相色谱仪、不同的色谱柱以及其他的影响因素(波长、流速、柱温、流动相的梯度、梯度时间程序),所得的相对校正因子(RPF)及其相对保留时间(RSD)。In order to test the new method, the experiment examines the existing different liquid chromatographs, different chromatographic columns and other influencing factors (wavelength, flow rate, column temperature, gradient of mobile phase, gradient time program) in the laboratory. factor (RPF) and its relative retention time (RSD).
色谱峰准确定位是保证“一测多评”法应用的前提,采用相对保留时间值(RRT)参数结合色谱图整体特征来定位。RRT=RTx/RTs,RTx:其他色谱峰保留时间RTs:内标物的色谱峰的保留时间,不同液相色谱仪的RCF的RSD范围在0.12-1.18,RRT的RSD的范围在0.2-1.36,所以不同液相色谱仪对方法的影响很小。不同波长的RCF的RSD的范围在0.26-2.03,RRT的RSD范围在0.53-1.83。不同流速的RCF的RSD的范围在0.53-1.72,RRT的RSD范围在0.33-1.65.不同柱温的RCF的RSD的范围在0.65-2.02,RRT的RSD范围在0.50-1.67流动相酸的RCF在0.65-1.77之间,RRT在0.46-2.30之间,对方法影响很小。Accurate positioning of chromatographic peaks is the premise to ensure the application of the "one-test, multiple-evaluation" method. The relative retention time (RRT) parameter is used to locate the chromatogram in combination with the overall characteristics of the chromatogram. RRT=RT x /RT s , RT x : retention time of other chromatographic peaks RT s : retention time of chromatographic peaks of internal standard, the RSD range of RCF of different liquid chromatographs is 0.12-1.18, and the range of RSD of RRT is 0.12-1.18 0.2-1.36, so different liquid chromatographs have little effect on the method. The RSD range of RCF with different wavelengths is 0.26-2.03, and the RSD range of RRT is 0.53-1.83. The RSD of RCF with different flow rates is in the range of 0.53-1.72, the RSD of RRT is in the range of 0.33-1.65. The RSD of RCF with different column temperatures is in the range of 0.65-2.02, the RSD of RRT is in the range of 0.50-1.67, and the RCF of mobile phase acid is in the range of 0.65-2.02. Between 0.65-1.77, RRT is between 0.46-2.30, which has little effect on the method.
一测多评法与外标法测定结果比较(mg/g)Comparison of measurement results between one test and multiple evaluation method and external standard method (mg/g)
注:5号峰为槲皮素 3-O-葡萄糖苷Note: Peak 5 is quercetin 3-O-glucoside
以Pearson相关系数表征本发明的方法与外标法所得结果的相关性可知,本发明的方法与外标法所得结果无显著差异。The Pearson correlation coefficient is used to characterize the correlation between the results obtained by the method of the present invention and the external standard method, and it can be seen that there is no significant difference between the results obtained by the method of the present invention and the external standard method.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810103484.0A CN108362809B (en) | 2018-02-01 | 2018-02-01 | Quality evaluation method of ginkgo leaf and extract and preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810103484.0A CN108362809B (en) | 2018-02-01 | 2018-02-01 | Quality evaluation method of ginkgo leaf and extract and preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108362809A CN108362809A (en) | 2018-08-03 |
CN108362809B true CN108362809B (en) | 2020-07-10 |
Family
ID=63004386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810103484.0A Expired - Fee Related CN108362809B (en) | 2018-02-01 | 2018-02-01 | Quality evaluation method of ginkgo leaf and extract and preparation thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108362809B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110824072B (en) * | 2019-12-18 | 2021-11-05 | 神威药业集团有限公司 | Method for constructing fingerprint of flavonoid in ginkgo leaf extract or preparation thereof |
CN111537656B (en) * | 2020-06-19 | 2021-07-20 | 劲牌有限公司 | Identification method of tartary buckwheat extract |
CN113995776B (en) * | 2020-07-27 | 2023-01-13 | 浙江康恩贝制药股份有限公司 | Ginkgo leaf flavone extract, preparation method thereof and characteristic map construction method |
CN113533270A (en) * | 2021-06-16 | 2021-10-22 | 万邦德制药集团有限公司 | Quality control method of ginkgo leaf dripping pills |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103110670A (en) * | 2012-10-23 | 2013-05-22 | 北京华润高科天然药物有限公司 | Preparation method for efficiently extracting separating high-purity flavone components from ginkgo leaf |
CN104523771A (en) * | 2015-01-13 | 2015-04-22 | 中国药科大学 | Ginkgo leaf total flavones and preparing method thereof |
CN106706809A (en) * | 2016-12-26 | 2017-05-24 | 河北神威药业有限公司 | Method for simultaneously determining contents of multiple components in Shuxuening injection |
CN106770828A (en) * | 2016-12-26 | 2017-05-31 | 河北神威药业有限公司 | It is a kind of while the method for determining multicomponent content in ginkgo biloba p.e and its preparation |
CN107064397A (en) * | 2017-06-16 | 2017-08-18 | 黑龙江珍宝岛药业股份有限公司 | A kind of Shu Xuening injection method of quality control that many evaluation amount methods and finger-print are surveyed based on one |
-
2018
- 2018-02-01 CN CN201810103484.0A patent/CN108362809B/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103110670A (en) * | 2012-10-23 | 2013-05-22 | 北京华润高科天然药物有限公司 | Preparation method for efficiently extracting separating high-purity flavone components from ginkgo leaf |
CN104523771A (en) * | 2015-01-13 | 2015-04-22 | 中国药科大学 | Ginkgo leaf total flavones and preparing method thereof |
CN106706809A (en) * | 2016-12-26 | 2017-05-24 | 河北神威药业有限公司 | Method for simultaneously determining contents of multiple components in Shuxuening injection |
CN106770828A (en) * | 2016-12-26 | 2017-05-31 | 河北神威药业有限公司 | It is a kind of while the method for determining multicomponent content in ginkgo biloba p.e and its preparation |
CN107064397A (en) * | 2017-06-16 | 2017-08-18 | 黑龙江珍宝岛药业股份有限公司 | A kind of Shu Xuening injection method of quality control that many evaluation amount methods and finger-print are surveyed based on one |
Non-Patent Citations (4)
Title |
---|
Rapid and Sensitive Determination of Major Active Ingredients and Toxic Components in Leaves Extract (EGb 761) by a Validated UPLC–MS-MS Method;Yao Wang et al;《Journal of Chromatographic Science》;20170109;第55卷(第4期);第459-464页 * |
一测多评法同时测定舒血宁注射液中6种黄酮类成分;张方 等;《中国药师》;20151231;第18卷(第10期);第1652-1656页 * |
一测多评法测定银杏叶提取物中7种黄酮类成分含量;杨艳模 等;《中国实验方剂学杂志》;20140430;第20卷(第8期);第82-85页 * |
指纹图谱结合一测多评模式在中药鱼腥草质量评价中的应用研究;何兵 等;《中国中药杂志》;20130831;第38卷(第16期);第2682-2689页 * |
Also Published As
Publication number | Publication date |
---|---|
CN108362809A (en) | 2018-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108362809B (en) | Quality evaluation method of ginkgo leaf and extract and preparation thereof | |
CN102879486B (en) | Method for screening traditional Chinese medicine effect related ingredients and model building method | |
CN103018371B (en) | Quality control method of sunset abelmoschus root medicinal material as well as extract and preparation of sunset abelmoschus root | |
CN106770828B (en) | A kind of method for simultaneous determination of multicomponent content in Ginkgo biloba extract and its preparation | |
CN106198782A (en) | A kind of can realize the content analysis of 18 components in Folium Ilicis and the method for quality control of similarity evaluation simultaneously | |
CN105911186A (en) | Measurement method of honeysuckle and radix scutellariae granule fingerprint spectrum | |
CN104407087B (en) | A method for simultaneous detection of gallic acid and ellagic acid in myrtle root | |
CN103364506A (en) | Quality control method for effective parts of pomelo flavedo and pomelo flavedo preparation | |
CN109765322A (en) | The characteristic spectrum construction method and quality determining method of schizonepeta | |
CN108896673A (en) | A kind of content assaying method of longleaf campanumoea root Content of Chlorogenic Acid, luteolin and apiolin | |
CN108426963B (en) | Method for constructing HPLC fingerprint of vinegar rhizoma cyperi | |
CN104764820A (en) | Method for determining content of active ingredients such as ephedrine hydrochloride and pseudoephedrine hydrochloride in pinellia ternata syrup | |
CN104502485B (en) | The quantitative analysis method of 6 chemical compositions in the compound Chinese medicinal preparation that is medicinal material by rhizoma dioscoreae nipponicae and wilsonii | |
CN114252541B (en) | A method for constructing the fingerprint of Xiaoer Xiaoji Zhike oral liquid and a method for quantitative determination of multi-indicators | |
CN107389821A (en) | A kind of method of active ingredient in measure ageratum oral liquid | |
CN108872410A (en) | A kind of method for building up and its finger-print of lung-nourishing semifluid extract finger-print | |
CN112858549A (en) | Quantitative fingerprint quality monitoring method for Shuanghuanglian oral liquid | |
CN109900829A (en) | A kind of method of quality control of particle for relieving heat and cough | |
CN104678004B (en) | A kind of method of quality control of Ge Shan blood-fat-lowering granule | |
CN110057950A (en) | A kind of construction method of the Pudilan sulfathiazole HPLC finger-print based on Detection wavelength switching | |
CN106770764B (en) | A kind of content assaying method of Xue bijing intermediate multi-target ingredient | |
CN106290643B (en) | A kind of method of quality control of Chinese medicine schizonepeta anti-lung cancer activity ingredient | |
CN102590435B (en) | Xipayi mouth rinse quality detection method | |
CN106770850B (en) | The structure and its quality determining method of the standard feature collection of illustrative plates of analgesic rheumatoid plaster | |
CN109557233B (en) | Method for determining content of multi-index components in white paeony root extracting solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200710 |